Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

CSPC

Obesity Weekly News

Obesity Video Recap—February 3, 2026

This biweekly Obesity video recap highlights key developments across clinical…

Onco_background

Oncology Today—January 5, 2026

This oncology roundup captures major regulatory approvals, strategic portfolio…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Lucid Diligence Brief: Candel Therapeutics $100m funding for CAN-2409 in localized prostate cancer
Public Health Today—February 20, 2026
Vaccines Video Recap—February 20, 2026
Vaccines Today—February 20, 2026
Respiratory Video Recap—February 20, 2026

Tags

advanced therapies AlloHeme Amulet 360 Autoimmune disease therapies bioinformatics cancer Cancer drug development ckd corporate venture capital Cytokine release syndrome DeepSeek-V3-FW diploid rabies vaccine drug pricing drug supply chain Echocardiography monitoring Elranatamab ESMO 2021 FDA gene therapy approvals FDA neuroscience approvals gene editing gene therapy approval hematology hepatitis D Insights investment Minimally invasive surgery Mycobacterium abscessus Infection nanotechnology NFTs in healthcare NMDA non viral vectors Obesity market trends oncology trials pharma Pulmonary hypertension–interstitial lung disease Rare disease drug pipeline remote patient monitoring Sapien M3 Sema4 surgical robotics synergies tissue engineering unconventional trial designs Vanscoy Rare Pharmacy Women’s health market trends

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Lucid Diligence Brief: Candel Therapeutics $100m funding for CAN-2409 in localized prostate cancer
Public Health Today—February 20, 2026
Vaccines Video Recap—February 20, 2026
Vaccines Today—February 20, 2026
Respiratory Video Recap—February 20, 2026

TAGS

advanced therapies AlloHeme Amulet 360 Autoimmune disease therapies bioinformatics cancer Cancer drug development ckd corporate venture capital Cytokine release syndrome DeepSeek-V3-FW diploid rabies vaccine drug pricing drug supply chain Echocardiography monitoring Elranatamab ESMO 2021 FDA gene therapy approvals FDA neuroscience approvals gene editing gene therapy approval hematology hepatitis D Insights investment Minimally invasive surgery Mycobacterium abscessus Infection nanotechnology NFTs in healthcare NMDA non viral vectors Obesity market trends oncology trials pharma Pulmonary hypertension–interstitial lung disease Rare disease drug pipeline remote patient monitoring Sapien M3 Sema4 surgical robotics synergies tissue engineering unconventional trial designs Vanscoy Rare Pharmacy Women’s health market trends

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy